Serum 25-hydroxyvitamin D levels are associated with carotid atherosclerosis in normotensive and euglycemic Chinese postmenopausal women: The Shanghai Changfeng study

BMC Cardiovascular Disorders

Volumn 14, Issue 1, 2014, Pages

  Ma, Hui ^a   Lin, Huandong ^a   Hu, Yu ^a   Li, Xiaoming ^a   He, Wanyuan ^a   Jin, Xuejuan ^a   Gao, Jian ^a   Zhao, Naiqing ^a   Liu, Zhenqi ^b   Gao, Xin ^a  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

25 hydroxyvitamin D (25 (OH) D); Carotid atherosclerosis; Carotid intima media thickness (CIMT); Carotid plaque

Indexed keywords

25 HYDROXYVITAMIN D; PARATHYROID HORMONE; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; ANTHROPOMETRY; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CHEMOLUMINESCENCE; CHINESE; FEMALE; HUMAN; KIDNEY FUNCTION; LIVER FUNCTION; MIDDLE AGED; POSTMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; VITAMIN BLOOD LEVEL; AGED; ANALOGS AND DERIVATIVES; ASIAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROTIC PLAQUE; BLOOD; CAROTID ARTERY DISEASE; CHINA; ECHOGRAPHY; ETHNOLOGY; PHYSIOLOGY;

AGED; ANTHROPOMETRY; ASIAN CONTINENTAL ANCESTRY GROUP; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CHINA; FEMALE; HUMANS; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; POSTMENOPAUSE; RISK FACTORS; VITAMIN D;

EID: 84965191695     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-14-197     Document Type: Article

References (40)

1. Zhao G, Ford ES, Li C, Croft JB: Serum 25-hydroxyvitamin D levels and all-cause and cardiovascular disease mortality among US adults with hypertension: the NHANES linked mortality study. J Hypertens 2012, 30(2):284-289.
2. Messenger W, Nielson CM, Li H, Beer T, Barrett-Connor E, Stone K, Shannon J: Serum and dietary vitamin D and cardiovascular disease risk in elderly men: a prospective cohort study. Nutr Metab Cardiovasc Dis 2012, 22(10):856-863.
3. Holick MF: Vitamin D deficiency. N Engl J Med 2007, 357(3):266-281.
4. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS: Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117(4):503-511.
5. Targher G, Bertolini L, Padovani R, Zenari L, Scala L, Cigolini M, Arcaro G: Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol (Oxf ) 2006, 65(5):593-597.
6. Wang L, Song Y, Manson JE, Pilz S, März W, Michaëlsson K, Lundqvist A, Jassal SK, Barrett-Connor E, Zhang C, Eaton CB, May HT, Anderson JL, Sesso HD: Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 2012, 5(6):819-829.
7. Deleskog A, Piksasova O, Silveira A, Gertow K, Baldassarre D, Veglia F, Sennblad B, Strawbridge RJ, Larsson M, Leander K, Gigante B, Kauhanen J, Rauramaa R, Smit AJ, Mannarino E, Giral P, Gustafsson S, östenson CG, Humphries SE, Tremoli E, de Faire U, Öhrvik J, Hamsten A: Serum 25-hydroxyvitamin D concentration in subclinical carotid atherosclerosis. Arterioscler Thromb Vasc Biol 2013, 33(11):2633-2638.
8. Blondon M, Sachs M, Hoofnagle AN, Ix JH, Michos ED, Korcarz C, Gepner AD, Siscovick DS, Kaufman JD, Stein JH, Kestenbaum B, de Boer IH: 25-Hydroxyvitamin D and parathyroid hormone are not associated with carotid intima-media thickness or plaque in the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol 2013, 33(11):2639-2645.
9. Park S, Lee BK: Vitamin D deficiency is an independent risk factor for cardiovascular disease in Koreans aged = 50 years: results from the Korean National Health and Nutrition Examination Survey. Nutr Res Pract 2012, 6(2):162-168.
10. Melamed ML, Michos ED, Post W, Astor B: 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008, 168(15):1629-1637.
11. Hypponen E, Berry D, Cortina-Borja M, Power C: 25-Hydroxyvitamin D and pre-clinical alterations in inflammatory and hemostatic markers: a cross sectional analysis in the 1958 British Birth Cohort. PLoS One 2010, 5:e10801.
12. Mosca L, Barrett-Connor E, Wenger NK: Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation 2011, 124(19):2145-2154.
13. Ma H, Lin H, Hofman A, Hu Y, Li X, He W, Jeekel J, Jin X, Gao J, Zhao N, Gao X: Low-grade albuminuria is associated with carotid atherosclerosis in normotensive and euglycemic Chinese middle-aged and elderly adults: the Shanghai Changfeng Study. Atherosclerosis 2013, 228(1):237-242.
14. Gao X, Hofman A, Hu Y, Lin H, Zhu C, Jeekel J, Jin X, Wang J, Gao J, Yin Y, Zhao N: The Shanghai Changfeng Study: a communitybased prospective cohort study of chronic diseases among middle-aged and elderly: objectives and design. Eur J Epidemiol 2010, 25(12):885-893.
15. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130(6):461-470.
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28(7):412-419.
17. Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, Najjar SS, Rembold CM, Post WS: American Society of Echocardiography Carotid Intima-Media Thickness Task Force: Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography. Carotid intima-media thickness Task Force Endorsed by the Society for vascular Medicine. J Am Soc Echocardiogr 2008, 21(2):93-111.
18. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee: Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003, 42(6):1206-1252.
19. American Diabetes Association: Standards of medical care in diabetes-2010. Diabetes Care 2010, 33(suppl 1):S11-S61.
20. Liu L, Chen M, Hankins SR, Nùñez AE, Watson RA,Weinstock PJ, Newschaffer CJ, Eisen HJ: Drexel Cardiovascular Health Collaborative Education, Research, and Evaluation Group: Serum 25-hydroxyvitamin D concentration and mortality from heart failure and cardiovascular disease, and premature mortality from all-cause in United States adults. Am J Cardiol 2012, 110(6):834-839.
21. Simon A, Megnien JL, Chironi G: The value of carotid intima-media thickness for predicting cardiovascular risk. Arterioscler Thromb Vasc Biol 2010, 30(2):182-185.
22. Kim SH, Reaven G: Sex differences in insulin resistance and cardiovascular disease risk. J Clin Endocrinol Metab 2013, 98(11):E1716-E1721.
23. Qiao Z, Li-Xing S, Nian-Chun P, Shu-Jing X, Miao Z, Hong L, Hui-Jun Z, Ming-Xian G, Song Z, Rui W, Ying H, Jing-Lu Z, Shuang C: Serum 25(OH)D Level and Parathyroid Hormone in Chinese Adult Population: A Cross-Sectional Study in Guiyang Urban Community from Southeast of China. Int J Endocrinol 2013, 2013:150461.
24. Lu L, Yu Z, Pan A, Hu FB, Franco OH, Li H, Li X, Yang X, Chen Y, Lin X: Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 2009, 32(7):1278-1283.
25. Xue Y: Serum levels of 25-hydroxyvitamin D in normal Beijing subjects. China Prev Med 1991, 25(3):177-179.
26. Yan L, Zhou B, Wang X, D'Ath S, Laidlaw A, Laskey MA, Prentice A: Older people in China and the United Kingdom differ in the relationships among parathyroid hormone, vitamin D, and bone mineral status. Bone 2003, 33(4):620-627.
27. Saedisomeolia A, Taheri E, Djalali M, Moghadam AM, Qorbani M: Association between serum level of vitamin D and lipid profiles in type 2 diabetic patients in Iran. J Diabetes Metab Disord 2014, 13(1):7.
28. Mattila C, Knekt P, Männistö S, Rissanen H, Laaksonen MA, Montonen J, Reunanen A: Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 2007, 30(10):2569-2570.
29. Grandi NC, Breitling LP, Vossen CY, Hahmann H, Wüsten B, März W, Rothenbacher D, Brenner H: Serum vitamin D and risk of secondary cardiovascular disease events in patients with stable coronary heart disease. Am Heart J 2010, 159(6):1044-1051.
30. Gouni-Berthold I, Krone W, Berthold HK: Vitamin D and cardiovascular disease. Curr Vasc Pharmacol 2009, 7(3):414-422.
31. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP: 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002, 110(2):229-238.
32. Li YC: Vitamin D regulation of the renin-angiotensin system. J Cell Biochem 2003, 88(2):327-331.
33. Rammos G, Tseke P, Ziakka S: Vitamin D, the renin-angiotensin system, and insulin resistance. Int Urol Nephrol 2008, 40(2):419-426.
34. Ohsawa M, Koyama T, Yamamoto K, Hirosawa S, Kamei S, Kamiyama R: 1alpha,25-dihydroxyvitamin D(3) and its potent synthetic analogs down-regulate tissue factor and up-regulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized LDL. Circulation 2000, 102(23):2867-2872.
35. Van der Schueren BJ, Verstuyf A, Mathieu C: Straight from D-Heart: vitamin D status and cardiovascular disease. Curr Opin Lipidol 2012, 23(1):17-23.
36. Schmidt N, Brandsch C, Kühne H, Thiele A, Hirche F, Stangl GI: Vitamin D receptor deficiency and low vitamin D diet stimulate aortic calcification and osteogenic key factor expression in mice. PLoS One 2012, 7(4):e35316.
37. Brandenburg VM, Vervloet MG, Marx N: The role of vitamin D in cardiovascular disease: from present evidence to future perspectives. Atherosclerosis 2012, 225(2):253-263.
38. Deluca HF, Cantorna MT: Vitamin D: Its role and uses in immunology. Faseb J 2001, 15(14):2579-2585.
39. Zittermann A1, Schleithoff SS, Tenderich G, Berthold HK, Körfer R, Stehle P: Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 2003, 41(1):105-112.
40. Oh J, Weng S, Felton SK, Bhandare S, Riek A, Butler B, Proctor BM, Petty M, Chen Z, Schechtman KB, Bernal-Mizrachi L, Bernal-Mizrachi C: 1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 2009, 120(8):687-698.